Morphic Therapeutic
MORF
$29.90
Share price
4.14%
Change (1 day)
-41.59%
Change (1 year)
Categories
Morphic Therapeutic (MORF) Fails to deliver data
Key failure to deliver metrics for Morphic Therapeutic:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.17 M
- Last 3 months FTD volume: $2.91 M
- Last year FTD volume: $13.52 M
Failures to deliver for Morphic Therapeutic (MORF) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Morphic Therapeutic (MORF) - since 2019
Volume in USD (price x number of shares), data since 2019Morphic Therapeutic (MORF) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.95 M | -76.5% |
| 2023 | $12.56 M | 62.89% |
| 2022 | $7.71 M | -93.04% |
| 2021 | $0.11 B | 221.46% |
| 2020 | $34.48 M | 1039.01% |
| 2019 | $3.02 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 OPKO Health
OPK | $40.6 M | $49.01 M | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.06 M | $0.41 M | 🇺🇸 USA |